#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Extraskeletal ossification Shprintzen-Goldberg syndrome Multiple system atrophy Adenocarcinoma gastric Neuroendocrine carcinoma metastatic Thrombocytosis Rhabdomyosarcoma Pleomorphic liposarcoma Acute graft versus host disease in liver Mantle cell lymphoma recurrent Short stature Pseudoxanthoma elasticum Cardiac failure acute Obesity Pulmonary tuberculosis More trials…

    Learn about Rare Diseases

    Gaucher’s disease type III Undifferentiated sarcoma – Treatment Alexander disease – Treatment Haemophilia A with anti factor VIII Factor IX deficiency – Diagnostics Shprintzen-Goldberg syndrome – Life with Disease Anaplastic thyroid cancer – Basic Information Osteosarcoma metastatic – Treatment Amyotrophic lateral sclerosis – Life with Disease Antithrombin III deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Betaine Citrate Regn7508 Bosentan PRILOCAINE HYDROCHLORIDE Dexamethasone Phosphate Rezvilutamide Abbv-668 Patritumab Deruxtecan Voriconazole Vamorolone PICLIDENOSON Ruxolitinib Sodium Hypochlorite Lerodalcibep Ict01 Clomifene Citrate Chlortalidone 18F-Psma-1007 Duloxetine VERTEPORFIN More therapies…

    Learn about Your Condition

    Mast cell activation syndrome Papulopustular rosacea Factor IX deficiency Ovarian cancer recurrent Hypertrophic scar Laryngeal leukoplakia Myxofibrosarcoma Ependymoma malignant Haemophilia Testis cancer Aplasia pure red cell Diabetic foot infection Familial hypertriglyceridaemia Biliary tract operation Pancreatic failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Haemophilia B without inhibitors

  • Study on the Effectiveness of Concizumab for Children Under 12 with Hemophilia A or B, With or Without Inhibitors

    Recruiting

    3 1 1
    Investigated Diseases:
    • Factor IX deficiency
    • Haemophilia B without inhibitors
    • Haemophilia A without inhibitors
    Investigated Drugs:
    • Concizumab
    Bulgaria France Greece Italy Lithuania Norway +4

  • Study on the Safety and Effectiveness of SerpinPC for Patients with Severe Hemophilia A or B

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Haemophilia A with anti factor VIII
    • Haemophilia B without inhibitors
    • Haemophilia A without inhibitors
    Belgium Bulgaria France Germany Italy Poland +1

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!